Adjuvant dendritic cell‐based tumour vaccination for children with malignant brain tumours

Abstract

In this exploratory study, HGG and ATRT seem to respond more favourably to vaccination than MB/PNET and ependymoma. Although preliminary, our results are promising and support further testing of DC-based immunotherapy in new treatment protocols for HGG and ATRT.